Medrobotics Corporation has proven to be one of the key players in the forte of robot-assisted surgery. With its distinguishing proficiency in robotics, the company provides of an innovative platform for MIS. The major driving factor for Medrobotics Corporation is to provide the least pain inducive medical service to a maximum number of patients, through their inventive and novel products.
One of the bellwether offerings of the company is the Flex® Robotic System, which is a robot-powered platform that enables surgeons to have single-site access and visualization of the otherwise difficult anatomical sections. The product embodies the use of a coherent multi-linked scope that helps in facile navigation around the human anatomy, coupled with a three-dimensional visual system. The coextensive structure makes this product even more flexible and maneuverable. The scope becomes a rigid surgical platform through which flexible instruments can be passed, for smooth execution of surgical procedures. Flex® Robotic System also provides robotic control over the Flex® Colorectal Drive which is the patient-contact portion designed to reach to the anus, rectum, and distal colon.
The major driving factor for Medrobotics Corporation is to provide the least pain inducive surgical service to the maximum number of patients, through their inventive and novel products
Another important offering of Medrobotics Corporation is its Flex® Retractor which is directed towards Transoral Robotic Surgery (TORS), Transoral Laser Microsurgery (TLM), and Flex® procedures. The convenient attributes of this instrument being light weight and with multiple blades makes it ideal for transoral surgeons. Being more cost-effective than other advanced retractors makes this product a beneficial entry into the field of robotic surgery.
A recent successful venture was the leveraging of Medrobotics Corporation’s product by a European hospital A.O. Universitaria Città della Salute e della Scienza di Torino, as a result of which, the entity became the first European medical institute to offer scar free, interventional endoscopic procedure.
All such significant offerings has helped Medrobotics Corporation cross a vital milestone in its envisioned path, by receiving the FDA regulatory clearance to market the Flex® Robotic System. It substantiates the product of the company as being the first of its kind platform for providing scar-free access in otolaryngology and colorectal vectors. As stated by the CEO Samuel Straface, Ph.D., “With this new FDA indication, the use of Medrobotics’ flexible robotic technology extends beyond natural orifices. This clearance is a vital step in our commitment to minimize the impact of surgery by offering less invasive procedures through a single incision in the abdomen or thoracic cavity versus the multiple incisions that are currently required.” The offerings of Medrobotics Corporation have been widely acclaimed and recognized for its progressive approach, through the Best-In-Show award at the Medical Design Excellence Awards (MDEA) and the best new product award at the Edison Awards, to name a few.
Medrobotics Corporation, in future, aims to expand their product offerings to other genres of surgery including transvaginal gynecological processes, through its unambiguous three-dimensional approach, alongside a robotic platform that is stable, precise and cost-effective, marking its products as a transformational step towards surgical revolution.